Stockscreener 앱 받기
14.71
0.75%
0.11
시간 외 거래:
14.71
Dr Reddys Laboratories Ltd Adr 주식(RDY)의 최신 뉴스
Asian Stocks Dipped As US-Listed ADRs Edged Lower - Finimize
Stock Picks Today: Infosys, Dr. Reddys Labs, Kajaria Ceramics, Tata Consumer Products On Brokerages Radar - NDTV Profit
Dr. Reddy’s Labs ADR earnings missed, revenue fell short of estimates - Investing.com Canada
Dr Reddys Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - NDTV Profit
Asian Stocks Mixed As S&P Asia 50 ADR Index Falls - Finimize
LLY Stock Quote Price and Forecast - CNN
HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold - MSN
Asian ADRs Retreat As Mixed Results Hit The Market - Finimize
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Morgan Stanley initiates coverage on Dr. Reddy’s stock with Equalweight rating - Investing.com India
Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong - GlobeNewswire Inc.
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Mixed Movements In Asian Equities As Some Sectors Shine - Finimize
Full Truck Alliance Co. Ltd. Sponsored ADR (NYSE:YMM) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - Defense World
Mather Group LLC. Buys 3,413 Shares of Haleon PLC Sponsored ADR (NYSE:HLN) - Defense World
Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Holdings Cut by Robeco Institutional Asset Management B.V. - MarketBeat
Asian Equities Traded in the US as ADRs Rise in Thursday Trading - 富途牛牛
Asian ADRs Climb With North And South Leaders - Finimize
Dr Reddy’s Breaks Past ₹1,330 Apex: SEBI RA Rajneesh Sharma Sees Trend Shift, Cautions Overbought Zone - Investing.com India
Dr Reddys Laboratories allots Equity shares - Business Standard
RDY’s Market Whiplash: 2.41% YTD Rise, 14.68% Rise in 30 Days - investchronicle.com
SBI Cards to WiproPrashanth Tapse suggests stocks to buy in the short term - Mint
Stocks Showing Rising Market Leadership: Dr. Reddy's Labs ADR Earns 81 RS Rating - Investor's Business Daily
Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize
Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech By Investing.com - Investing.com Nigeria
Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech - Investing.com Australia
HSBC upgrades Dr. Reddy’s stock rating citing semaglutide prospects - Investing.com Australia
Asian Equities Gain In US Markets' Positive Start - Finimize
Dr. Reddy’s Laboratories Receives USFDA Observations After Recent Inspection - TipRanks
Bank of America Corp DE Buys 1,057,584 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Dr Reddys Laboratories shares climb over 1.1% amid increased trading volume in today's session - Moneycontrol
Axa S.A. Has $1.23 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Indian ADRs Surge in US Markets as Wall Street soars after US-China trade talks - Moneycontrol
Shares To Buy For Short-term: Analysts recommend 5 largecap, 2 midcap stocks; Britannia, Dr Reddy's, TCS on the list - Zee Business
Wells Fargo & Company MN Has $124,000 Holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World
Asian Equities Climb Despite Weekly Losses - Finimize
Dr. Reddy’s Earnings: Year-End Numbers Look Solid as Demand and Prescription Trends Remain Resilient - Morningstar
Dr. Reddy’s Laboratories Grants Stock Options to Employees in May 2025 - TipRanks
Insider’s View: Deciphering Six Flags Entertainment Corp (FUN)’s Financial Health Through Ratios - DWinneX
Balance Sheet Breakdown: Astrazeneca plc ADR (AZN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Ratio Examination: Dr. Reddy’s Laboratories Ltd. ADR (RDY)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX
Financial Analysis: Spotify Technology S.A (SPOT)’s Ratios Unveil Key Insights - DWinneX
1.51%
0.26%
자본화:
|
볼륨(24시간):